Cargando…

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent

OBJECTIVE—: Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages are associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine–polarized ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hohensinner, Philipp J., Baumgartner, Johanna, Kral-Pointner, Julia B., Uhrin, Pavel, Ebenbauer, Benjamin, Thaler, Barbara, Doberer, Konstantin, Stojkovic, Stefan, Demyanets, Svitlana, Fischer, Michael B., Huber, Kurt, Schabbauer, Gernot, Speidl, Walter S., Wojta, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627534/
https://www.ncbi.nlm.nih.gov/pubmed/28818858
http://dx.doi.org/10.1161/ATVBAHA.117.309383
_version_ 1783268734459183104
author Hohensinner, Philipp J.
Baumgartner, Johanna
Kral-Pointner, Julia B.
Uhrin, Pavel
Ebenbauer, Benjamin
Thaler, Barbara
Doberer, Konstantin
Stojkovic, Stefan
Demyanets, Svitlana
Fischer, Michael B.
Huber, Kurt
Schabbauer, Gernot
Speidl, Walter S.
Wojta, Johann
author_facet Hohensinner, Philipp J.
Baumgartner, Johanna
Kral-Pointner, Julia B.
Uhrin, Pavel
Ebenbauer, Benjamin
Thaler, Barbara
Doberer, Konstantin
Stojkovic, Stefan
Demyanets, Svitlana
Fischer, Michael B.
Huber, Kurt
Schabbauer, Gernot
Speidl, Walter S.
Wojta, Johann
author_sort Hohensinner, Philipp J.
collection PubMed
description OBJECTIVE—: Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages are associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine–polarized macrophages are inversely related with disease progression. To establish a functional cause for these observations, we analyzed extracellular matrix degradation phenotypes in polarized macrophages. APPROACH AND RESULTS—: We provide evidence that proinflammatory polarized macrophages rely on membrane-bound proteases including MMP-14 (matrix metalloproteinase-14) and the serine protease uPA (urokinase plasminogen activator) together with its receptor uPAR for extracellular matrix degradation. In contrast, Th2 cytokine alternatively primed macrophages do not show different proteolytic activity in comparison to unpolarized macrophages and lack increased localization of MMP-14 and uPA receptor to the cell membrane. Nonetheless, they express the highest amount of the serine protease uPA. However, uPA activity is blocked by similarly increased expression of its inhibitor PAI-1 (plasminogen activator inhibitor 1). When inhibiting PAI-1 or when analyzing macrophages deficient in PAI-1, Th2 cytokine–polarized macrophages display the same matrix degradation capability as proinflammatory-primed macrophages. Within atherosclerotic lesions, macrophages positive for the alternative activation marker CD206 express high levels of PAI-1. In addition, to test changed tissue remodeling capacities of alternatively activated macrophages, we used a bleomycin lung injury model in mice reconstituted with PAI-1(−/−) bone marrow. These results supported an enhanced remodeling phenotype displayed by increased fibrosis and elevated MMP activity in the lung after PAI-1 loss. CONCLUSIONS—: We were able to demonstrate matrix degradation dependent on membrane-bound proteases in proinflammatory stimulated macrophages and a forced proteolytical quiescence in alternatively polarized macrophages by the expression of PAI-1.
format Online
Article
Text
id pubmed-5627534
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-56275342017-10-17 PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent Hohensinner, Philipp J. Baumgartner, Johanna Kral-Pointner, Julia B. Uhrin, Pavel Ebenbauer, Benjamin Thaler, Barbara Doberer, Konstantin Stojkovic, Stefan Demyanets, Svitlana Fischer, Michael B. Huber, Kurt Schabbauer, Gernot Speidl, Walter S. Wojta, Johann Arterioscler Thromb Vasc Biol Translational Sciences OBJECTIVE—: Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages are associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine–polarized macrophages are inversely related with disease progression. To establish a functional cause for these observations, we analyzed extracellular matrix degradation phenotypes in polarized macrophages. APPROACH AND RESULTS—: We provide evidence that proinflammatory polarized macrophages rely on membrane-bound proteases including MMP-14 (matrix metalloproteinase-14) and the serine protease uPA (urokinase plasminogen activator) together with its receptor uPAR for extracellular matrix degradation. In contrast, Th2 cytokine alternatively primed macrophages do not show different proteolytic activity in comparison to unpolarized macrophages and lack increased localization of MMP-14 and uPA receptor to the cell membrane. Nonetheless, they express the highest amount of the serine protease uPA. However, uPA activity is blocked by similarly increased expression of its inhibitor PAI-1 (plasminogen activator inhibitor 1). When inhibiting PAI-1 or when analyzing macrophages deficient in PAI-1, Th2 cytokine–polarized macrophages display the same matrix degradation capability as proinflammatory-primed macrophages. Within atherosclerotic lesions, macrophages positive for the alternative activation marker CD206 express high levels of PAI-1. In addition, to test changed tissue remodeling capacities of alternatively activated macrophages, we used a bleomycin lung injury model in mice reconstituted with PAI-1(−/−) bone marrow. These results supported an enhanced remodeling phenotype displayed by increased fibrosis and elevated MMP activity in the lung after PAI-1 loss. CONCLUSIONS—: We were able to demonstrate matrix degradation dependent on membrane-bound proteases in proinflammatory stimulated macrophages and a forced proteolytical quiescence in alternatively polarized macrophages by the expression of PAI-1. Lippincott Williams & Wilkins 2017-10 2017-09-27 /pmc/articles/PMC5627534/ /pubmed/28818858 http://dx.doi.org/10.1161/ATVBAHA.117.309383 Text en © 2017 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Translational Sciences
Hohensinner, Philipp J.
Baumgartner, Johanna
Kral-Pointner, Julia B.
Uhrin, Pavel
Ebenbauer, Benjamin
Thaler, Barbara
Doberer, Konstantin
Stojkovic, Stefan
Demyanets, Svitlana
Fischer, Michael B.
Huber, Kurt
Schabbauer, Gernot
Speidl, Walter S.
Wojta, Johann
PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title_full PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title_fullStr PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title_full_unstemmed PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title_short PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
title_sort pai-1 (plasminogen activator inhibitor-1) expression renders alternatively activated human macrophages proteolytically quiescent
topic Translational Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627534/
https://www.ncbi.nlm.nih.gov/pubmed/28818858
http://dx.doi.org/10.1161/ATVBAHA.117.309383
work_keys_str_mv AT hohensinnerphilippj pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT baumgartnerjohanna pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT kralpointnerjuliab pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT uhrinpavel pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT ebenbauerbenjamin pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT thalerbarbara pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT dobererkonstantin pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT stojkovicstefan pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT demyanetssvitlana pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT fischermichaelb pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT huberkurt pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT schabbauergernot pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT speidlwalters pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent
AT wojtajohann pai1plasminogenactivatorinhibitor1expressionrendersalternativelyactivatedhumanmacrophagesproteolyticallyquiescent